Secondly, both SMR and uvMR suggested a positive association between PCSK9 expression and PCSK9-mediated LDL cholesterol levels with the risk of AS and AIS, and between NPC1L1 expression and NPC1L1-mediated LDL cholesterol levels with the risk of SVS. Here, NPC1L1 is linked to androgen insensitivity syndrome.